Bibliografia
1. Triantafillidis JK, Merikas E, Georgopoulos F. Current and emerging drugs for the treatment of inflammatory bowel disease. Drug Des Devel Ther 2011; 5:185-210.
2. Vecchi M, Vernia P, Riegler G et al. Therapeutic landscape for ulcerative colitis: where is the Adacolumn(®) system and where should it be? Clin Exp Gastroenterol 2013; 6:1-7.
3. Hanai H, Takeda Y, Eberhardson M et al. The mode of actions of the Adacolumn therapeutic leucocytapheresis in patients with inflammatory bowel disease: a concise review. Clin Exp Immunol 2011; 163:50-8.
4. Saniabadi AR, Hanai H, Fukunaga K et al. Therapeutic leukocytapheresis for inflammatory bowel disease. Transfus Apher Sci 2007; 37:191-200.
5. Sands BE, Sandborn WJ, Feagan B et al; Adacolumn Study Group. A randomized, double-blind, sham-controlled study of granulocyte/monocyte apheresis for active ulcerative colitis. Gastroenterology 2008; 135:400-9.
6. Sacco R, Tanaka T, Yamamoto T et al. Adacolumn leucocytapheresis for ulcerative colitis: clinical and endoscopic features of responders and unresponders. Expert Rev Gastroenterol. Hepatol. Early online, 1–7 (2014) doi: 10.1586/17474124.2014.953060.
7. Habermalz B, Sauerland S. Clinical effectiveness of selective granulocyte, monocyte adsorptive apheresis with the Adacolumn device in ulcerative colitis. Dig Dis Sci 2010; 55:1421-8.
8. Yoshino T, Nakase H, Minami N et al. Efficacy and safety of granulocyte and monocyte adsorption apheresis for ulcerative colitis: a meta-analysis. Dig Liver Dis 2014; 46:219-26.
9. Passalacqua S, Ferraro PM, Bresci G et al. The Italian Registry of Therapeutic Apheresis: granulocyte-monocyte apheresis in the treatment of inflammatory bowel disease. A multicentric study. J Clin Apher 2011; 26:332-7.
10. Sacco R et al. Long term efficacy of Granulocyte-monocyte-apheresis in ulcerative colitis. The Italian Registry of Therapeutic Apheresis. P242, Journal of Crohn’s & Colitis Volume 8/S1 (2014).
11. Imperiali G, Terpin M, Amato A et al. Granulocyte and Monocyte Apheresis (GMA) Adacolumn® in mild to moderate ulcerative colitis patients with steroid resistance or dependence and azathioprine intolerance or resistance: a prospective multicenter study (preliminary data). ECCO 2014, Copenhagen, Danimarca.
12. Cabriada JL, Domènech E, Ibargoyen N et al. Leukocytapheresis for steroid-dependent ulcerative colitis in clinical practice: results of a nationwide Spanish registry. J Gastroenterol 2012; 47:359-65.
13. Dignass A, Akbar A, Bonaz B. Efficacy and safety of granulocyte, monocyte/macrophage adsorptive apheresis in steroid-dependent active UC with insufficient response or intolerance to immunosuppressants and/or biological therapies (the ART trial): Results at 12 weeks. ECCO 2014, Copenhagen, Danimarca.
|